Close
28/05/2015
Synchrotron light applications for the pharmaceutical industry
More than forty people from the pharmaceutical sector attended the workshop organised by the ALBA Synchrotron on May 7.

Researchers from the MSPD, CLAESS, XALOC, NCD and MISTRAL ALBA beam lines have shown the available state-of-the-art techniques and the advantages that they offer in this field: fast data acquisition and shorter experiments, cost savings and, in the case of X-ray microscopy, suppression of ethical conflicts because this technique can be a previous step before clinical essays with animals and persons.

The companies Enantia and Almirall, which have already collaborated with the ALBA Synchrotron, have commented their own experiences at the facility. Enantia, specialised in research solutions for other companies, has detailed different examples. For Almirall, the analysis of polymorphic compounds – performed at ALBA – has increased its quality control, verifying and quantifying purity grades.

News based on the press release issued by the ALBA synchrotron.

Image: ALBA synchrotron. Structure of a herpesvirus nuclease-antiviral complex. Data collected at the Xaloc beam line (Bongarzone, S., Nadal, M. & Coll, M., IBMB)

More news

30/07/2014 Barcelona among the top 10 cities in the world 24/07/2014 Researchers prove the effectiveness of a new drug against malaria using synchrotron light 17/07/2014 Creation of the Health Technologies Cluster 10/07/2014 An international team of scientists led by researchers from the UAB creates the world's first magnetic hose 03/07/2014 CaixaBank and Oracle set up a Big Data Centre of Excellence in the Barcelona Synchrotron Park 26/06/2014 The Barcelona Supercomputing Center hosts two important new international projects
39 40 41 42 43 44 45 46 47 48 49